US Patent Issued to JANSSEN BIOTECH on April 7 for "Methods and compositions for prediction of response to a therapy of an inflammatory bowel disease" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,510, issued on April 7, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.).

"Methods and compositions for prediction of response to a therapy of an inflammatory bowel disease" was invented by Frederic Baribaud (Broomall, Pa.), Carrie Brodmerkel (West Chester, Pa.), Xilin Li (Wallingford, Pa.), Takahiro Sato (Philadelphia), Shannon Telesco (Lansdale, Pa.), Feifei Yang (Wayne, Pa.) and Prerak Desai (Lansdale, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Biomarkers that are indicative of the response to the therapy of the inflammatory bowel disease, including ulcerative colitis (UC) and Crohn's disease (CD), are described. Also described are pro...